United States securities and exchange commission logo





              October 19, 2022

       David Rosenberg
       Chairman and Co-Chief Executive Officer
       Ignyte Acquisition Corp.
       640 Fifth Avenue, 4th Floor
       New York, NY 10019

                                                        Re: Ignyte Acquisition
Corp.
                                                            Proxy Statement on
Schedule 14A
                                                            Filed September 23,
2022
                                                            File No. 001-39951

       Dear David Rosenberg:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.




              Sincerely,


              Division of Corporation Finance

              Office of Life Sciences
       cc:                                              Scott Cowan, Esq.